89 related articles for article (PubMed ID: 2957118)
21. Determinants of rebound thrombin activity after cessation of heparin in patients undergoing coronary interventions.
Watkins MW; Luetmer PA; Schneider DJ; Witmer WT; Vaitkus PT; Sobel BE
Cathet Cardiovasc Diagn; 1998 Jul; 44(3):257-64. PubMed ID: 9676792
[TBL] [Abstract][Full Text] [Related]
22. Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension.
Douglas JT; Shah M; Lowe GD; Belch JJ; Forbes CD; Prentice CR
Thromb Haemost; 1982 Feb; 47(1):54-5. PubMed ID: 6176042
[TBL] [Abstract][Full Text] [Related]
23. The resuscitative fluid you choose may potentiate bleeding.
Brummel-Ziedins K; Whelihan MF; Ziedins EG; Mann KG
J Trauma; 2006 Dec; 61(6):1350-8. PubMed ID: 17159676
[TBL] [Abstract][Full Text] [Related]
24. Off-pump coronary artery bypass operation does not increase procoagulant and fibrinolytic activity: preliminary results.
Englberger L; Immer FF; Eckstein FS; Berdat PA; Haeberli A; Carrel TP
Ann Thorac Surg; 2004 May; 77(5):1560-6. PubMed ID: 15111143
[TBL] [Abstract][Full Text] [Related]
25. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
Brister SJ; Ofosu FA; Buchanan MR
Thromb Haemost; 1993 Aug; 70(2):259-62. PubMed ID: 8236131
[TBL] [Abstract][Full Text] [Related]
26. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
[TBL] [Abstract][Full Text] [Related]
27. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
Kim YS; Murkin JM; Adams SJ
Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
[TBL] [Abstract][Full Text] [Related]
28. Dissociation of thrombin generation and platelet secretion in diabetes mellitus.
Rosove MH; Berliner JA; Harwig SS; Frank HJ
Diabetes Res; 1985 Jul; 2(4):171-3. PubMed ID: 2935351
[TBL] [Abstract][Full Text] [Related]
29. HN-11500--a novel thromboxane A2 receptor antagonist with antithrombotic activity in humans at arterial blood flow conditions.
Roald HE; Barstad RM; Engen A; Kierulf P; Skjørten F; Sakariassen KS
Thromb Haemost; 1994 Jan; 71(1):103-9. PubMed ID: 8165627
[TBL] [Abstract][Full Text] [Related]
30. Platelet activation in bypass surgery for critical limb ischemia.
Mohan IV; Mikhailidis DP; Stansby GP
Vasc Endovascular Surg; 2007; 41(4):322-9. PubMed ID: 17704335
[TBL] [Abstract][Full Text] [Related]
31. Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stenting.
Weltermann A; Fritsch P; Kyrle PA; Schoenauer V; Heinze G; Wojta J; Christ G; Huber K
Thromb Res; 2003; 112(1-2):19-24. PubMed ID: 15013268
[TBL] [Abstract][Full Text] [Related]
32. [Clinical significance of fibrinopeptide A in surgery].
Fuwa S
Nihon Geka Gakkai Zasshi; 1984 Mar; 85(3):191-205. PubMed ID: 6236358
[TBL] [Abstract][Full Text] [Related]
33. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
[TBL] [Abstract][Full Text] [Related]
34. Activation of coagulation system in dilated cardiomyopathy: comparison of patients with and without left ventricular thrombus.
Riza Erbay A; Turhan H; Aksoy Y; Senen K; Yetkin E
Coron Artery Dis; 2004 Aug; 15(5):265-8. PubMed ID: 15238823
[TBL] [Abstract][Full Text] [Related]
35. Low molecular mass heparin instead of unfractionated heparin during infrainguinal bypass surgery.
Swedenborg J; Nydahl S; Egberg N
Eur J Vasc Endovasc Surg; 1996 Jan; 11(1):59-64. PubMed ID: 8564488
[TBL] [Abstract][Full Text] [Related]
36. Increased coagulation activity of the pleura after tube drainage and quinacrine instillation in malignant pleural effusion.
Agrenius V; Chmielewska J; Widström O; Blombäck M
Eur Respir J; 1991 Oct; 4(9):1135-9. PubMed ID: 1836767
[TBL] [Abstract][Full Text] [Related]
37. Association of heparin-resistant thrombin activity with acute ischemic complications of coronary interventions.
Oltrona L; Eisenberg PR; Lasala JM; Sewall DJ; Shelton ME; Winters KJ
Circulation; 1996 Nov; 94(9):2064-71. PubMed ID: 8901652
[TBL] [Abstract][Full Text] [Related]
38. [Short-term heparin therapy in obliterating arteriopathies of the lower limbs].
Arrigo F; Coglitore S; Giannetto M; Bramanti O; Barbera C; Consolo F
Boll Soc Ital Cardiol; 1977; 22(3):273-82. PubMed ID: 617274
[No Abstract] [Full Text] [Related]
39. Coagulation and platelet activation after retinal vein occlusions.
Mari D; Santori M; Bertoni G; Mannucci PM
Haemostasis; 1982; 11(4):189-92. PubMed ID: 6215293
[TBL] [Abstract][Full Text] [Related]
40. Heparin abolishes the chemotherapy-induced increase in plasma fibrinopeptide A levels.
Edwards RL; Klaus M; Matthews E; McCullen C; Bona RD; Rickles FR
Am J Med; 1990 Jul; 89(1):25-8. PubMed ID: 2368789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
